Medtronic (MDT) Restructuring Costs (2013 - 2026)

Medtronic (MDT) has 14 years of Restructuring Costs data on file, last reported at -$138.0 million in Q2 2026.

• For the quarter ending Q2 2026, Restructuring Costs fell 144.95% year-over-year to -$138.0 million; the trailing twelve-month figure through Apr 2026 stood at $114.0 million (down 75.11% YoY), and the FY2026 full-year result was $113.0 million, down 64.35% from the prior year.
• Restructuring Costs fell to -$138.0 million in Q2 2026, from $172.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $307.0 million in Q2 2025 to a low of -$138.0 million in Q2 2026.
• A 5-year average of $106.5 million and a median of $84.5 million in 2022 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs soared 7650.0% in 2022 and tumbled 144.95% in 2026, its largest moves.
• Tracing MDT's Restructuring Costs over 5 years: stood at $95.0 million in 2022, then decreased by 4.21% to $91.0 million in 2023, then plunged by 49.45% to $46.0 million in 2024, then tumbled by 71.74% to $13.0 million in 2025, then sank by 1161.54% to -$138.0 million in 2026.
• Business Quant data shows MDT's Restructuring Costs at -$138.0 million in Q2 2026, $172.0 million in Q1 2026, and $13.0 million in Q4 2025.